Nanobiotix S.A. - Chronological SEC Filings

Search Ctrl + K

Nanobiotix S.a.

Pharmaceutical Preparations

NASDAQ.NBTX

60 Rue De Wattignies, Paris, I0, 75012

- Categorized
- Chronological
- Ownership by Owner
- Insider Transactions
- Institutional Owners
- Filings by Form Type
- Transcripts
- Your Highlights
- Articles & Bylaws
- Indentures
- Material contracts
- Plans of Reorganization
- Underwriting Agreements
- Google Finance
- SEC EDGAR

© 2023 Gheko, Inc. Terms of Service Privacy Policy Browse Companies

Latest Filings – Ownership

Latest Filings – Non-Ownership

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.

Report Of Foreign Private Issuer Pursuant To Rules 13a-16 And 15d-16.